Yuning Ma

Number 197 Ruijin Second Road
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Deciphering Platelet Transcriptomic Profiles in Antiphospholipid Syndrome: Insights into Their Role as Immunological Players.

Deciphering Platelet Transcriptomic Profiles in Antiphospholipid Syndrome: Insights into Their Role as Immunological Players.

Journal: International journal of molecular sciences
Published: May 10, 2026

Long-term clinical outcomes and safety of rituximab in refractory neuropsychiatric systemic lupus erythematosus: a real-world single-center study.

Long-term clinical outcomes and safety of rituximab in refractory neuropsychiatric systemic lupus erythematosus: a real-world single-center study.

Journal: Clinical rheumatology
Published: January 27, 2026

A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease-Like Autoinflammatory Syndrome.

A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease-Like Autoinflammatory Syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 12, 2025

Identification of a metabolic-immune crosstalk in Still's disease: monocyte/macrophage-derived immunometabolite itaconate dictates hepatic immunopathology via the CXCL10-CD8 T cell axis.

Identification of a metabolic-immune crosstalk in Still's disease: monocyte/macrophage-derived immunometabolite itaconate dictates hepatic immunopathology via the CXCL10-CD8 T cell axis.

Journal: Experimental & molecular medicine
Published: August 21, 2025

Exploring rituximab efficacy in systemic lupus erythematosus with pulmonary hemorrhage: a retrospective case series from a single center.

Exploring rituximab efficacy in systemic lupus erythematosus with pulmonary hemorrhage: a retrospective case series from a single center.

Journal: Clinical rheumatology
Published: March 29, 2025

Genotoxic effects of aristolochic acid I on functional human-induced hepatocyte-like cells.

Genotoxic effects of aristolochic acid I on functional human-induced hepatocyte-like cells.

Journal: Mutagenesis
Published: December 31, 2024

Correction: Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Correction: Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Journal: BMC medicine
Published: October 15, 2024

TLR9 decreases FOXO3 expression to prevent excessive inflammation in macrophage activation syndrome.

TLR9 decreases FOXO3 expression to prevent excessive inflammation in macrophage activation syndrome.

Journal: iScience
Published: April 25, 2024

Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome.

Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome.

Journal: Blood
Published: February 20, 2024

Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.

Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.

Journal: Journal of autoimmunity
Published: November 10, 2023

Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Journal: BMC medicine
Published: August 07, 2023

The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still's disease.

The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still's disease.

Journal: Rheumatology (Oxford, England)
Published: June 06, 2023
Showing 1-12 of 34

Last Updated: 09/26/2026